Publications by authors named "C Pages"

Claim this Profile
N
Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma: the randomized phase 1b/2 Morpheus-Melanoma trial.
Georgina V Long, Nitya Nair, Daniel Marbach, Richard A Scolyer, Sabine Wilson, Cecile Pages

Nat Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ribonuclease toxin RelE1 inhibits growth of Mycobacterium tuberculosis through specific cleavage of the ribosomal anti-Shine-Dalgarno region.
Xue Han, Izaak N Beck, Moise Mansour, Tom J Arrowsmith, Roland Barriot

Nucleic Acids Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on dermatological toxicities of immune checkpoint inhibitors.
Davide Fattore, Giuseppe Lauletta, Cecile Pages, Valentine Theret, Vincent Sibaud

Presse Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: A nationwide real-life study in France (NEOMEL).
Charlée Nardin, Charlotte Cavalieri, Céleste Lebbé, Emilie Gérard, Marc Puyraveau, Cecile Pages

Br J Dermatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International survey on training of dermatology residents in supportive oncodermatology: the RESCUE study.
Ariadna Ortiz-Brugués, Davide Fattore, Marie Boileau, Ana-Maria Forsea, Zoe Apalla

Support Care Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis